H. Koller (Vienna, Austria), W. Pohl (Vienna, Austria), E. Russi (Zurich, Switzerland), H. Watz (Grosshansdorf, Germany)
Fibroblast growth factor 23 (FGF23) and hypophosphatemia in patients with COPD
M. Elsammak, A. Attia, M. Suleman (Dammam, Saudi Arabia)
|  |
Low testosterone in chronic obstructive pulmonary disease
E. Cojocaru, A. Turcanu, R. M. Bercea, C. Cojocaru (Iasi, Romania)
| |
The study of proton magnetic resonance spectroscopy on hippocampus in rats with chronic obstructive pulmonary disease
X. Ling, Y. Lin (Nanjing, China)
| |
COPD: Different psychology status (PS) in the patients with different co-morbidity rate
K. Gashynova (Dnipropetrovsk, Ukraine)
| |
Arterial hypertension (AH) and endothelial function (EF) in patients with COPD
K. Gashynova, T. Pertseva, N. Yefimova (Dnipropetrovsk, Ukraine)
| |
The impact of comorbidities related to BMI in COPD patients
C. Cabrera Lopez, J. Zagaceta, C. Cote, M. Divo, J. P. De Torres, J. M. Marín, C. Casanova, V. Pinto-Plata, J. Zulueta, B. Celli, S. Carrizo (Las Palmas de G.C., Pamplona, Zaragoza, Santa Cruz de Tenerife, Spain; Tampa, Boston, United States Of America)
|  |
Fibrinogen, health status and hospitalization in patients with moderate to severe COPD
V. Hodgev, B. Marinov, R. Kalinov, L. Vladimirova-Kitova, F. Nikolov, S. Kostianev (Plovdiv, Bulgaria)
| |
Ego defense mechanisms in COPD: Impact on health-related quality of life and dyspnoea severity
S. C. Albuquerque, E. R. Carvalho, R. S. Lopes, I. S. Marques, D. S. Macêdo, E. D. Pereira, T. N. Hyphantis, A. F. Carvalho (Fortaleza, Brazil; Ioannina, Greece)
| |
Heart rate variability during the night in chronic obstructive pulmonary disease
R. Inchingolo, G. M. Corbo, G. A. Sgueglia, G. Lanza, S. Valente (Roma, Italy)
| |
Changes in bronchial mucous membrane depending on the stage of COPD (I, II)
T. Pertseva, I. Ivakh, O. Plekhanova (Dnipropetrovsk, Ukraine)
| |
GERD and anxiety in patients with severe COPD
S. Alsayed (Jeddah, Saudi Arabia)
| |
Is COPD a risk factor for thyroid disorders?
L. Ciobanu, V. Maciuc, R. Costan, A. Gorga, P. A. Bobirca, S. Corduneanu (Iasi, Romania)
| |
Systemic inflammation and nutritive status in patients with COPD
K. Gashynova (Dnipropetrovsk, Ukraine)
| |
Bone mineral density in patients with COPD depending on pulmonary function parameters
O. Kharevich, I. Lapteva, A. Tomashevsky, N. Porahonko, N. Vasilieva, V. Vadzianava (Minsk, Belarus)
| |
Alpha1-antitrypsin deficiency: An analysis of patient subgroups of the German registry
C. Guttmann, P. M. Lepper, M. Bachhuber, C. Herr, A. R. Koczulla, C. Vogelmeier, R. Bals (Homburg, Marburg, Germany)
| |
Vitamin D receptor polymorphisms and exacerbation frequency in COPD
J. Quint, G. Donaldson, N. Wassef, J. Hurst, M. Thomas, J. Wedzicha (London, United Kingdom)
| |
Is there any correlation between apoptosis of the cells from bronchoalveolar lavage fluid (BALF) and the progression of chronic obstructive pulmonary disease (COPD)?
A. Nowicka, H. Batura-Gabryel, M. Kaczmarek, J. Sikora, K. Swierkocki, A. Czyz (Poznan, Poland)
| |
The regional distribution of body fat mass (BFM) in men with chronic obstructive pulmonary disease (COPD)
A. Makarevich, S. Lemiasheuskaya (Minsk, Belarus)
| |